SUBSCRIBE
SUBSCRIBE

Press Releases

Browse the the latest press releases from around the industry. Want to filter press releases by date, keyword, and more? Search here.

THE LATEST
Press Releases
BioMark Diagnostics Highlights Fiscal Year 2025 Achievements and Sets Bold Strategic Milestones for 2025 - 2026
July 30, 2025
 · 
5 min read
Press Releases
PharmaDrug Signs LOI to Acquire Equity Interest in Canurta Inc.
July 30, 2025
 · 
13 min read
Press Releases
Sharp Therapeutics Corp. Engages Rho Inc. to Help Advance Compounds into Clinical Trials for Gaucher Disease
July 30, 2025
 · 
5 min read
Press Releases
Embolization Particles Market Projected to Reach USD 3.79 Billion by 2034 at 12.27% CAGR
July 30, 2025
 · 
1 min read
Press Releases
Cell & Gene Therapy Contract Research Organizations Market Size to Surpass USD 13.76 Billion by 2034
July 30, 2025
 · 
1 min read
Press Releases
Biologics Market Size to Lead USD 1,126.96 Billion by 2034 Driven by Rising Demand for Advanced Therapies and Technological Advancements
July 30, 2025
 · 
1 min read
Press Releases
Survey: Patients on GLP-1 Receptor Agonists Are Concerned About Muscle Loss
About 36% of patients indicate moderate to very high concern about muscle loss, and up to 55% are making correlated lifestyle changes; 61% of patients consulted their general physician before starting treatment
July 30, 2025
 · 
1 min read
Press Releases
United Therapeutics Corporation Reports Record Second Quarter 2025 Financial Results
July 30, 2025
 · 
13 min read
Press Releases
Bausch + Lomb Announces Second-Quarter 2025 Results
July 30, 2025
 · 
19 min read
Press Releases
Madrigal Pharmaceuticals Enters into Exclusive Global License Agreement for Oral GLP-1 Receptor Agonist with CSPC Pharmaceutical Group Limited
July 30, 2025
 · 
7 min read
Press Releases
Sandoz signs non-binding term sheet with Evotec SE to acquire its Just-Evotec Biologics in-house development and manufacturing capabilities in Toulouse, France
July 30, 2025
 · 
4 min read
Press Releases
Press Release: Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma
July 30, 2025
 · 
6 min read
Press Releases
Strong sales acceleration of QUVIVIQ drives Idorsia toward profitability – H1 2025 results
July 30, 2025
 · 
16 min read
Press Releases
AB Science receives regulatory approval from European countries to initiate third stage of Phase I/II study combining its molecule AB8939 with venetoclax for the treatment of AML
July 30, 2025
 · 
9 min read
Press Releases
Evotec SE and Sandoz AG Planning Potential Sale of Just - Evotec Biologics Toulouse Site
July 30, 2025
 · 
1 min read
Press Releases
Evotec and Sandoz Evolve their Strategic Partnership and Agree on Potential Sale of Just - Evotec Biologics Toulouse Site
July 30, 2025
 · 
6 min read
Press Releases
Faron Announces Acceptance of Bexmarilimab Data for Oral Presentation at ESMO 2025
July 30, 2025
 · 
4 min read
Press Releases
Rakovina Therapeutics Highlights Long-Standing Collaboration with the University of British Columbia and the Vancouver Prostate Centre
July 30, 2025
 · 
4 min read
Press Releases
Takeda Announces First-Quarter FY2025 Results With Significant Late-Stage Pipeline Progression
July 30, 2025
 · 
10 min read
Press Releases
Viridian Therapeutics Announces Collaboration and License Agreement with Kissei Pharmaceutical to Develop and Commercialize Veligrotug and VRDN-003 in Japan with an Upfront Payment of $70 Million and up to $315 Million in Milestone Payments
July 30, 2025
 · 
7 min read
Press Releases
uniQure Announces Second Quarter 2025 Financial Results and Highlights of Recent Company Progress
July 30, 2025
 · 
14 min read
Press Releases
Novo Nordisk lowers sales and operating profit outlook for 2025
July 30, 2025
 · 
6 min read
Press Releases
EyePoint Completes Enrollment of Pivotal Phase 3 Trials for DURAVYU™ in Wet Age-Related Macular Degeneration
July 30, 2025
 · 
14 min read
Press Releases
Castle Biosciences to Present at the Canaccord Genuity 45th Annual Growth Conference
July 30, 2025
 · 
1 min read
Press Releases
PharmaDrug Inc.: Correction to News Release Dated July 30, 2025
July 30, 2025
 · 
14 min read
Press Releases
TauGen Files US Patent Application for Innovative Drug Candidates Targeting Traumatic Brain Injury (TBI)
July 30, 2025
 · 
1 min read
Press Releases
INmune Bio to Publish Video Detailing MINDFuL Trial Findings of XPro™ Presented at the Alzheimer’s Association International Conference
July 30, 2025
 · 
4 min read
Press Releases
Pharmazz Inc. Announces Enrollment of First Patient in Phase 3 Clinical Trial of Sovateltide for Treating Patients with Cerebral Ischemic Stroke
July 30, 2025
 · 
5 min read
Press Releases
Harrow To Report Second Quarter 2025 Financial Results After Market Close on August 11, 2025
July 30, 2025
 · 
1 min read
Press Releases
Krystal Biotech to Report Second Quarter 2025 Financial Results on August 4, 2025
July 30, 2025
 · 
1 min read
Press Releases
Ocular Therapeutix™ to Report Second Quarter 2025 Financial Results on August 5, 2025
July 30, 2025
 · 
1 min read
Press Releases
ARTBIO Announces $132 Million Series B Financing to Advance Pipeline of Alpha Radioligand Therapies and Expand Manufacturing and Supply Chain Infrastructure
July 30, 2025
 · 
3 min read
Press Releases
MIRA Pharmaceuticals Announces FDA Clearance of IND for Ketamir-2, Enabling U.S. Clinical Trials in Neuropathic Pain
July 30, 2025
 · 
8 min read
Press Releases
Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease
July 30, 2025
 · 
11 min read
Load More